Head and neck cancers
Conditions
Interventions
Gold Standard:Paraffin-embedded histopathological findings
Index test:Fluorescence probe N188-ICG
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with newly diagnosed or recurrent head and neck malignant tumors (including but not limited to squamous cell carcinoma and adenocarcinoma of the oral cavity, pharynx, and larynx, as well as nasopharyngeal carcinoma). 2. Patients with head and neck malignant tumors who have surgical indications and can tolerate surgery.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women. 2. Patients without a confirmed clinical diagnosis or who have undergone radiochemotherapy, immunotherapy, targeted therapy, or any other anti-tumor treatment within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in fluorescence intensity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic performance of fluorescence signal (ROC curve); | — |
Countries
China
Contacts
Public ContactQianhui Qiu
Guangdong Provincial People's Hospital
Outcome results
None listed